Skip to main content

Table 3 Protective efficacy of C-KCE-HA against H5N1 lethal virus HM/06 challenge in ducks

From: Efficient strategy for constructing duck enteritis virus-based live attenuated vaccine against homologous and heterologous H5N1 avian influenza virus and duck enteritis virus infection

Challenge virus

Challenge time pv

Vaccine

Virus isolation from the swabs (shedding/total log 10 EID 50 /mL)

No. surviving/total

Day 3 pc

Day 5 pc

Day 7 pc

Oropharyngeal

Cloacal

Oropharyngeal

Cloacal

Oropharyngeal

Cloacal

HM/06

1 week

C-KCE-HA

0/7

0/7

0/7

0/7

0/7

0/7

7/7

C-KCE

7/7(2.1 ± 0.9)

6/7(2.5 ± 0.3)

—

—

—

—

0/7

PBS

7/7(3.4 ± 1.2)

7/7(3.8 ± 0.4)

—

—

—

—

0/7

3 weeks

C-KCE-HA

0/7

0/7

0/7

0/7

0/7

0/7

7/7

C-KCE

7/7(4.1)

7/7(3.3 ± 0.5)

—

—

—

—

0/7

PBS

7/7(3.6 ± 0.7)

7/7(2.5 ± 1.1)

—

—

—

—

0/7

12 weeks

C-KCE-HA

0/7

0/7

0/7

0/7

0/7

0/7

7/7

C-KCE

7/7(2.6 ± 0.8)

7/7(3.1 ± 0.6)

—

—

—

—

0/7

PBS

7/7(2.9 ± 0.6)

6/7(2.3 ± 1.1)

—

—

—

—

0/7

36 weeks

C-KCE-HA

0/7

0/7

0/7

0/7

0/7

0/7

7/7

C-KCE

7/7(2.5 ± 0.6)

5/7(2.8 ± 0.3)

—

—

—

—

0/7

PBS

7/7(2.7 ± 0.9)

6/7(2.4 ± 0.6)

—

—

—

—

0/7

  1. One-month-old SPF ducks were used in these studies. Groups of seven ducks were inoculated subcutaneously with 105 PFU of C-KCE-HA, 105 PFU of C-KCE or with PBS as a control. They then were challenged intramuscularly with 100-fold DLD50 heterologous (HM/06) AIVs at 1 week, 3 weeks, 12 weeks or 24 weeks post-vaccination (pv). Oropharyngeal and cloacal swabs were collected on days 3, 5, and 7 post-challenge (pc) and titrated in SPF eggs. All of the ducks in C-KCE and PBS groups died within 5 days. The horizontal line indicates that the animals had died by that time point.